Expansion Therapeutics Is A Biotechnology Company Focused On Developing Oral Medicines For Severe Rna Mediated Diseasesincluding Neurodegenerative Disordersfounded In 2016The Company Operates From Locations In Boston And Cambridgemassachusettsand Jupiterfloridawith Some Sources Also Mentioning San Diegocaliforniait Leverages The Research Of Its Scientific Foundermatthew Ddisneyph D From The Scripps Research Institute The Company Specializes In Creating Small Molecule Medicines That Target Rna Through Its Proprietary Smirna Platformthis Platform Allows For The Development Of Specific Rna Modulators Aimed At Treating Various Diseasesparticularly Those With Limited Treatment Optionsexpansion Therapeutics Is Committed To Building A Portfolio Of Novel Rna Targeted Drug Candidates And Has Been Involved In Clinical Trials And Research To Advance Its Innovative Therapies
